Apramycin(APM) antibody/antigen (BSA/OVA/KLH conjugated hapten)

anti-Apramycin(APM) antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)

Target products collectionGo to Antibiotics diagnostics products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-SMT-16-11. BSA-Apramycin(APM)
2. Anti-Apramycin(APM) mouse monoclonal antibody
$2709.00
GMP-SMT-16-21. OVA-Apramycin(APM)
2. Anti-Apramycin(APM) mouse monoclonal antibody
$2709.00
GMP-SMT-16-31. BSA-Apramycin(APM)
2. Anti-Apramycin(APM) human monoclonal antibody
$2709.00
GMP-SMT-16-41. OVA-Apramycin(APM)
2. Anti-Apramycin(APM) human monoclonal antibody
$2709.00
GMP-SMT-16-Ag-1BSA-Apramycin(APM)$756.00
GMP-SMT-16-Ag-2OVA-Apramycin(APM)$756.00
GMP-SMT-16-Ab-1Anti-Apramycin(APM) mouse monoclonal antibody$1953.00
GMP-SMT-16-Ab-2Anti-Apramycin(APM) human monoclonal antibody$1953.00

Size: 1mg | 10mg | 100mg



Product Description


BSA-Apramycin(APM)

Cat No.GMP-SMT-16-Ag-1
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates BSA-Apramycin(APM) with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Apramycin(APM) had been validated with our anti-Hapten antibody Anti-Apramycin(APM) mouse monoclonal antibody via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
Formulation & ReconstitutionLyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


OVA-Apramycin(APM)

Cat No.GMP-SMT-16-Ag-2
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates OVA-Apramycin(APM) with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Apramycin(APM) had been validated with our anti-Hapten antibody Anti-Apramycin(APM) mouse monoclonal antibody via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
Formulation & ReconstitutionLyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Anti-Apramycin(APM) mouse monoclonal antibody

Cat No.GMP-SMT-16-Ab-1
Host of AntibodyMouse IgG
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Lateral flow immunoassay (LFIA);
ELISA IC50 (ppb)0.00
Products descriptionThe anti-Hapten antibody against hapten Apramycin(APM) had been validated with our hapten hapten-carrier conjugates BSA-Apramycin(APM) via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
Formulation & ReconstitutionLyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Anti-Apramycin(APM) human monoclonal antibody

Cat No.GMP-SMT-16-Ab-2
Host of AntibodyHuman IgG1
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Lateral flow immunoassay (LFIA);
ELISA IC50 (ppb)0.00
Products descriptionThe anti-Hapten antibody against hapten Apramycin(APM) had been validated with our hapten hapten-carrier conjugates BSA-Apramycin(APM) via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
Formulation & ReconstitutionLyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Biomarker Information


    1. Apramycin (APM): An Introduction

    Apramycin, often referred to as APM, is a critical antibiotic classified under the category of aminoglycosides. It has gained significant recognition and utilization in the realm of veterinary medicine, particularly in the context of managing bacterial infections in livestock. This includes applications in poultry and swine, where the demand for effective antibacterial agents is high.

    2. Antibacterial Efficacy of Apramycin

    Apramycin is celebrated for its potent antibacterial properties, which have a particular affinity for combating Gram-negative bacteria. This is of paramount importance because many bacterial strains that afflict animals, especially those in the gastrointestinal tracts, are Gram-negative in nature. Gram-negative bacteria are often known for their resistance to conventional antibiotics, making Apramycin a valuable alternative for maintaining animal health and productivity.

    3. Regulatory Oversight in Veterinary Medicine

    In the world of veterinary medicine, the use of Apramycin is subject to stringent regulatory oversight. This regulatory scrutiny is driven by the need to monitor its administration carefully and ensure that residues do not accumulate in animal products intended for human consumption. The accumulation of antibiotic residues in animal-derived food products poses significant risks to public health, as it can lead to the development of antibiotic resistance in humans.

    4. The Imperative of Measuring Apramycin Levels

    The measurement of Apramycin levels is a critical undertaking for several compelling reasons:

    4.1 Regulatory Compliance and Safety

    Accurate measurement of Apramycin levels is indispensable to guarantee compliance with regulatory standards. Ensuring that Apramycin residues do not exceed permissible limits is vital to prevent the inadvertent presence of APM residues in animal-derived food products, which could pose substantial risks to human health. The monitoring of APM levels is thus essential to uphold the safety of the food supply chain.

    4.2 Quality Assurance

    Monitoring Apramycin levels is an integral component of quality assurance protocols within the veterinary and food production industries. By verifying that APM residues remain within established safety limits, quality control measures can be implemented to assure the safety and purity of animal-derived food products. This ensures that consumers are protected from the potential health hazards associated with excessive antibiotic residues in their food.

    4.3 Veterinary Prudence

    In the realm of veterinary medicine, the quantification of Apramycin levels is crucial for veterinary prudence. It serves as a means to confirm the judicious usage of this antibiotic. Overexposure to Apramycin can lead to the development of antibiotic resistance in animals, which is a concerning issue in both veterinary and human medicine. By accurately measuring and controlling APM levels, veterinarians can contribute to the responsible use of antibiotics and the avoidance of unintended overexposure.

    4.4 Research Advancements

    The meticulous assessment of Apramycin levels also plays a significant role in ongoing research endeavors. These research efforts are aimed at refining veterinary practices and fostering the development of more efficacious antibiotics. By studying the pharmacokinetics and pharmacodynamics of Apramycin, researchers can enhance our understanding of how this antibiotic interacts with bacterial infections and develop strategies to optimize its use for the betterment of animal health.

    Conclusion

    In summation, Apramycin, designated as APM, is a vital tool in veterinary medicine for combating bacterial infections, particularly those caused by Gram-negative bacteria in livestock, such as poultry and swine. The strict regulatory oversight of Apramycin usage is essential to prevent antibiotic residues in animal products for human consumption. Measuring Apramycin levels is indispensable for regulatory compliance, quality assurance, veterinary prudence, and advancing scientific research in the field of veterinary medicine. This antibiotic plays a pivotal role in both animal health and food safety, making it a critical subject of study and regulation in the modern era.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.